Article

Rapid and Durable Protection Against Marburg Virus with a Single-Shot ChAd3-MARV GP Vaccine

2021-12-25

Abstract excerpt

Marburg virus (MARV) causes a severe hemorrhagic fever disease in primates with mortality rates in humans up to 90%. Since 2018, MARV has been identified as a priority pathogen by the WHO, needing urgent research and development of countermeasures due to the high public health risk it poses. Recently, the first case of MARV in West Africa underscored the significant outbreak potential of this virus. The potential...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d7225f66-2604-5e1e-8790-25b7e93f88ba
DOI: 10.1101/2021.12.22.472410

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Rapid and Durable Protection Against Marburg Virus with a Single-Shot ChAd3-MARV GP VaccineDOI 10.1101/2021.12.22.472410Read

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challengeSemantic proximity Read

Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Zaire ebolavirus, Sudan ebolavirus, Marburg and Lassa virusesSemantic proximity Read

Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary ReportSemantic proximity Read

Increasing Occurrence of Marburg Virus Outbreaks in Africa: Risk Assessment for Public HealthSemantic proximity Read

Induction of Broad Cytotoxic T Cells by Protective DNA Vaccination Against Marburg and EbolaSemantic proximity Read

Generation and characterization of protective antibodies to Marburg virusSemantic proximity Read

Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trialsSemantic proximity Read

A novel intranasal administration adenoviral vector-based platform for rapid COVID-19 vaccine developmentSemantic proximity Read

Emergence of Marburg Virus Disease in West Africa amid COVID-19 and Ebola: Efforts, Challenges, and Recommendations to Prevent the Next Public Health CrisisSemantic proximity Read

Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman PrimatesSemantic proximity Read

Vaccinomics strategy for developing a unique multi-epitope monovalent vaccine against Marburg marburgvirusSemantic proximity Read

An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primatesSemantic proximity Read